Symposium Looks at Lung Cancer Technology Innovations

Closing Plenary Addresses Access to Screening, Drugs

Panel Summarizes Immunotherapy Decision-Making for NSCLC

COVID-19 A Roadblock to Effective Lung Cancer Care in 2022

IASLC CEO Reflects on WCLC 2022

Unclear Informed Consent Forms May Be a Barrier to Trial Participation

Get Up to Date on SCLC Brain Metastases, Neuroendocrine Tumors

Data Supports Smoking Cessation as Part Active Lung Cancer Treatment

KEYNOTE-604 Follow-Up Results Continue to Show Clinically Meaningful Improvement

Study Shows Shorter-Term Assessments Underestimate Pollution Exposure

POSEIDON Analysis Shows Sustained Benefit with Triplet Regimen Regardless of Mutational Status

Program Covers Broad Spectrum of Topics in Thoracic Oncology